novo nordisk cagrilintide Nordisk's next-gen obesity drug CagriSema trial results disappoint investors Healthy Returns: What's next for

But the FDA flagged a serious adverse event, including a death, associated with an IV ipamorelin infusion (although it wasnt clear whether the peptide directly caused the participant's death)

PMCID: PMC11853175

After 40 weeks, 78% to 85% of adults taking Mounjaro achieved an HbA1c below 7%, compared with 23% of adults taking a placebo

Light and UV Exposure UV light breaks peptide bonds directly and accelerates oxidation of light-sensitive amino acid residues

These therapeutic approaches are currently regarded as experimental and off-label, and patients should be fully informed of the limited empirical support for their efficacy and safety in these contexts